Romlusevimab

Tax included
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
MedChemExpress 
HY-P99889

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
CAS
2509447-08-7